Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04969874
Other study ID # RC31/21/0023
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 2024
Est. completion date September 2026

Study information

Verified date December 2023
Source University Hospital, Toulouse
Contact Anais Galtier
Phone 05 67 77 18 01
Email galtier.a@chu-toulouse.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will assess the feasibility of monthly post rehabilitation remote monitoring, using the "MAX Educ" webvision app, in patients with sequelae of aerodigestive cancer treatments.


Description:

The patients included in the study will benefit from a monthly video follow-up via the WEB tool "MAX Educ" during the first 6 months of their discharge from the rehabilitation center. They will be contacted each month during 5 months by the CRIL speech therapist for an interview (20 to 30 minutes). The interview will take place in 2 stages; at first, a discussion phase, during which the speech therapist will take simple news of the patient. The second phase, more formal, will be the opportunity to collect the data necessary for the validation of the secondary endpoints. To do this, the speech therapist will use the Deglutition Handicap Index (DHI) and an interview grid. The interview will be conducted using an interview sheet previously written by the project team. The following elements will be discussed: the perceived swallowing handicap (DHI), the instructions related to diet and their daily application, ongoing rehabilitation follow-ups, notable events as well as his psycho-emotional experience in relation to said disorders. After signing the consent and verifying the eligibility criteria, all patients will be assessed upon discharge from the rehabilitation center by means of video swallowing fluoroscopy, allowing the deglutition score to be established. EORTC Quality of Life Questionnaire (QLQ) QLQ-30 and its annex H & N35 and the DHI will also be completed at the inclusion visit at T0. They will then be monitored monthly by video from Month 1 to Month 5. During the end of research visit at 6 months, all the patients included will be reviewed in follow-up consultation with a doctor and a speech therapist within the intensive rehabilitation center for laryngectomees (which corresponds to the standard follow-up) and evaluated by video swallowing fluoroscopy. EORTC QLQ-30, EORTC QLQ-H & N35 quality of life questionnaires and the DHI will also have to be completed.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date September 2026
Est. primary completion date September 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Patient aged 18 or over and treated for cancer of the upper aero-digestive tract: - Patient having spent a stay at the intensive rehabilitation center for laryngectomees - Patient with a medical diagnosis of swallowing disorders at risk of inhalation - Patient having the possibility of accessing a device allowing the use of the software by video (smartphone, tablet and / or computer) - Informed consent signed by the patient. - Patient affiliated to a social security scheme or equivalent Exclusion Criteria: - Progressive neurological disease leading to cognitive disorders - Patient with guardianship, curators or legal protection - Inability to give consent - Patient participating in another research including an exclusion period still in progress - Patient with speech therapy whose frequency is greater than 1 weekly session

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Remote follow-up
The feeling of swallowing will be assessed at the end of the stay at the rehabilitation center, which corresponds to the first visit, and then every month for 5 months during remote interviews and on discharge with the Deglutition Handicap Index (DHI), a self-assessment questionnaire for the swallowing handicap. The quality of life will be assessed at the firs visit and 6 months after using the EORTC QLQ 30 quality of life scale and the H&N annex, a self-assessment questionnaire on the quality of life for people with cancer of the head and neck. The satisfaction of users and the interest of city health professionals in the use of the "MAX Educ" tool as part of a monthly monitoring will be collected via the TUQ questionnaire, through the MAX platform at Month 6.

Locations

Country Name City State
France CHU Toulouse Toulouse

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Toulouse Ligue contre le cancer, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary patient attendance at monthly remote monitoring Attendance will be evaluated by measuring the rate of patients who participated in at least 3 webvisions out of 5 and at the final visit in face-to-face consultation, compared to the number of patients included. Month 6 : end of follow-up
Secondary felt swallowing The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow Month 0 : before follow-up
Secondary felt swallowing The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow Month 1 of follow-up
Secondary felt swallowing The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow Month 2 of follow-up
Secondary felt swallowing The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow Month 3 of follow-up
Secondary felt swallowing The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow Month 4 of follow-up
Secondary felt swallowing The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow Month 5 of follow-up
Secondary felt swallowing The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow Month 6 of follow-up
See also
  Status Clinical Trial Phase
Completed NCT03705936 - Metaplasticity in Human Pharyngeal Motor Cortex N/A
Completed NCT00475943 - Movement of Epiglottis During Swallowing N/A
Terminated NCT03588806 - Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills Phase 4
Not yet recruiting NCT05452135 - Cognitive - Motor Dual Task and Swallowing
Not yet recruiting NCT03390972 - Dexmedetomidine and Swallowing Function Phase 4
Completed NCT04114617 - Physiological Flow of Liquids in Healthy Swallowing